Acyl coenzyme A : cholesterol acyltransferase (ACAT), the enzyme catalyzing the hepatic cholesterol esterification, could be involved in the modified availability of cholesterol detectable in proliferating systems. While no significant variations are detectable in the regenerating liver, the modified ACAT activity during liver development and its differential sensitivity to the in vitro stimulation of modulatory systems suggest an involvement of the enzyme in this proliferating process.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF01119593DOI Listing

Publication Analysis

Top Keywords

acat activity
8
short term
4
term regulation
4
regulation acyl
4
acyl coa
4
cholesterol
4
coa cholesterol
4
cholesterol acyl
4
acyl transferase
4
transferase acat
4

Similar Publications

Aging and apolipoprotein E4 () are the two most significant risk factors for late-onset Alzheimer's disease (LOAD). Compared to , disrupts cholesterol homeostasis, increases cholesteryl esters (CEs), and exacerbates neuroinflammation in brain cells, including microglia. Targeting CEs and neuroinflammation could be a novel strategy to ameliorate -dependent phenotypes.

View Article and Find Full Text PDF

The multifaceted anti-atherosclerotic properties of herbal flavonoids: A comprehensive review.

Pharmacol Res

January 2025

School of Pharmacy, Macau University of Science and Technology, Macau 999078, China; Laboratory of Cardiovascular Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address:

Atherosclerosis (AS) is a major etiological factor underpinning a spectrum of cardiovascular diseases, leading to cerebral infarction, coronary artery disease, and peripheral vascular disease. The chronic progression of AS, spanning from initial plaque formation to the occurrence of acute cardiovascular events, underscores the complexity of AS and the challenges it presents in terms of treatment. Currently, the clinical management of AS relies predominantly on statins and proprotein convertase subtilisin/kexin type 9 inhibitors, which primarily aim to reduce low-density lipoprotein levels and have demonstrated some therapeutic efficacy.

View Article and Find Full Text PDF

How active cholesterol coordinates cell cholesterol homeostasis: Test of a hypothesis.

Prog Lipid Res

November 2024

Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637, United States of America.

How do cells coordinate the diverse elements that regulate their cholesterol homeostasis? Our model postulates that membrane cholesterol forms simple complexes with bilayer phospholipids. The phospholipids in the plasma membrane are of high affinity; consequently, they are fully complexed with the sterol. This sets the resting level of plasma membrane cholesterol.

View Article and Find Full Text PDF
Article Synopsis
  • Aging and the presence of the APOE4 gene are major risk factors for late-onset Alzheimer's disease (LOAD), leading to increased neuroinflammation and cholesterol imbalances in brain cells.
  • The study highlights that inhibiting the cholesterol storage enzyme ACAT1 can reduce harmful cholesteryl esters and inflammation by modulating TLR4 levels in microglia, which are immune cells in the brain.
  • Treatment with a nanoparticle-formulated ACAT inhibitor, F12511, shows promise in decreasing inflammatory markers and TLR4 protein levels in the brains of aged APOE4 mice, suggesting it may be a potential therapeutic strategy for LOAD.
View Article and Find Full Text PDF

Aging is the major risk factor for Alzheimer's disease (AD). In the aged brain, myelin debris accumulates and is cleared by microglia. Phagocytosed myelin debris increases neutral lipid droplet content in microglia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!